About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Precigen, Inc. - Common Stock (NQ:PGEN)

7.430 -0.010 (-0.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 444
Open 7.430
Bid (Size) 7.320 (700)
Ask (Size) 8.020 (1,100)
Prev. Close 7.440
Today's Range 7.430 - 7.430
52wk Range 2.942 - 7.490
Shares Outstanding 252,419,690
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Precigen (PGEN) Q2 2026 Earnings Call Transcript ↗
PAPZIMEOS revenue surged 145.8% sequentially as company posts first profitable quarter. 
Via The Motley Fool
Topics Earnings
News headline image
Precigen Q2 Earnings Call Highlights ↗
Precigen (NASDAQ:PGEN) reported a sharp increase in second-quarter revenue from its PAPZIMEOS launch, with the company reaching quarterly profitability less than a year after the therapy’s August 2025... 
Via MarketBeat
Topics Earnings

Performance

YTD
+73.6%
+73.6%
1 Month
+35.3%
+35.3%
3 Month
+73.6%
+73.6%
6 Month
+64.7%
+64.7%
1 Year
+131.5%
+131.5%

More News

Read More
What's going on in today's after hours session ↗
Via Chartmill
Precigen Inc (NASDAQ:PGEN) Flashes Perfect Technical Rating and Explosive Sales Growth in Minervini Screen ↗
Via Chartmill
Precigen Inc (NASDAQ:PGEN) Stock Surges on Narrower Loss and Commercial Transition After FDA Approval ↗
Via Chartmill
Precigen Stock Up 280% in a Year — Is FDA Approval Behind This Big New Investor Bet? ↗
Via The Motley Fool
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
Via ACCESS Newswire
News headline image
Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Precigen Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Precigen (PGEN) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
Via ACCESS Newswire
News headline image
These Analysts Boost Their Forecasts On Precigen Following Q4 Results ↗
Via Benzinga
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Precigen (PGEN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Inside One Fund's $21 Million Bet on Hilton Grand Vacations Stock ↗
Via The Motley Fool
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Precigen Inc (NASDAQ:PGEN) Q3 2025 Earnings: Revenue Soars But Wider Loss Dampens Investor Sentiment ↗
Via Chartmill
News headline image
Precigen (PGEN) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Exploring Precigen's Earnings Expectations ↗
Via Benzinga
News headline image
Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares ↗
Via The Motley Fool

Frequently Asked Questions

Is Precigen, Inc. - Common Stock publicly traded?
Yes, Precigen, Inc. - Common Stock is publicly traded.
What exchange does Precigen, Inc. - Common Stock trade on?
Precigen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Precigen, Inc. - Common Stock?
The ticker symbol for Precigen, Inc. - Common Stock is PGEN on the Nasdaq Stock Market
What is the current price of Precigen, Inc. - Common Stock?
The current price of Precigen, Inc. - Common Stock is 7.430
When was Precigen, Inc. - Common Stock last traded?
The last trade of Precigen, Inc. - Common Stock was at 08/20/26 04:00 PM ET
What is the market capitalization of Precigen, Inc. - Common Stock?
The market capitalization of Precigen, Inc. - Common Stock is 1.88B
How many shares of Precigen, Inc. - Common Stock are outstanding?
Precigen, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.